BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10963459)

  • 1. Reevaluation of ascorbate in cancer treatment: emerging evidence, open minds and serendipity.
    Padayatty SJ; Levine M
    J Am Coll Nutr; 2000 Aug; 19(4):423-5. PubMed ID: 10963459
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ascorbate induces autophagy in pancreatic cancer.
    Cullen JJ
    Autophagy; 2010 Apr; 6(3):421-2. PubMed ID: 20400857
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orthomolecular oncology: a mechanistic view of intravenous ascorbate's chemotherapeutic activity.
    González MJ; Miranda-Massari JR; Mora EM; Jiménez IZ; Matos MI; Riordan HD; Casciari JJ; Riordan NH; Rodríguez M; Guzmán A
    P R Health Sci J; 2002 Mar; 21(1):39-41. PubMed ID: 12013679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intravenous vitamin C in the supportive care of cancer patients: a review and rational approach.
    Klimant E; Wright H; Rubin D; Seely D; Markman M
    Curr Oncol; 2018 Apr; 25(2):139-148. PubMed ID: 29719430
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose vitamin C (ascorbic acid) therapy in the treatment of patients with advanced cancer.
    Ohno S; Ohno Y; Suzuki N; Soma G; Inoue M
    Anticancer Res; 2009 Mar; 29(3):809-15. PubMed ID: 19414313
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of high dose ascorbate administration on L-10 tumor growth in guinea pigs.
    Casciari JJ; Riordan HD; Miranda-Massari JR; Gonzalez MJ
    P R Health Sci J; 2005 Jun; 24(2):145-50. PubMed ID: 16116933
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular mechanisms of pharmacological doses of ascorbate on cancer cells.
    Venturelli S; Sinnberg TW; Niessner H; Busch C
    Wien Med Wochenschr; 2015 Jun; 165(11-12):251-7. PubMed ID: 26065536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with intravenous administration of ascorbic acid: achievable levels in blood for different states of inflammation and disease in cancer patients.
    Mikirova N; Casciari J; Riordan N; Hunninghake R
    J Transl Med; 2013 Aug; 11():191. PubMed ID: 23947403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of ascorbic acid to horses.
    Snow DH; Gash SP; Cornelius J
    Equine Vet J; 1987 Nov; 19(6):520-3. PubMed ID: 3504762
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidants in tears and plasma: Inter-relationships and effect of vitamin C supplementation.
    Choy C; Benzie I; Cho P
    Curr Eye Res; 2003 Jul; 27(1):55-60. PubMed ID: 12868009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum ascorbic acid concentrations in previously unsupplemented greyhounds after administration of a single dose of ascorbic acid intravenously or per os.
    Scott KC; Hill RC; Lewis DD; Gronwall R; Sundstrom DA; Jones GL; Harper J
    J Anim Physiol Anim Nutr (Berl); 2002 Aug; 86(7-8):222-8. PubMed ID: 15379908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Final report of the safety assessment of L-Ascorbic Acid, Calcium Ascorbate, Magnesium Ascorbate, Magnesium Ascorbyl Phosphate, Sodium Ascorbate, and Sodium Ascorbyl Phosphate as used in cosmetics.
    Elmore AR
    Int J Toxicol; 2005; 24 Suppl 2():51-111. PubMed ID: 16154915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor cells have decreased ability to metabolize H
    Doskey CM; Buranasudja V; Wagner BA; Wilkes JG; Du J; Cullen JJ; Buettner GR
    Redox Biol; 2016 Dec; 10():274-284. PubMed ID: 27833040
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic doses of ascorbate act as a prooxidant and decrease growth of aggressive tumor xenografts in mice.
    Chen Q; Espey MG; Sun AY; Pooput C; Kirk KL; Krishna MC; Khosh DB; Drisko J; Levine M
    Proc Natl Acad Sci U S A; 2008 Aug; 105(32):11105-9. PubMed ID: 18678913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Direct spectrophotometric measurement of supra-physiological levels of ascorbate in plasma.
    Witmer JR; Wetherell BJ; Wagner BA; Du J; Cullen JJ; Buettner GR
    Redox Biol; 2016 Aug; 8():298-304. PubMed ID: 26928133
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced antitumor activity of vitamin C via p53 in cancer cells.
    Kim J; Lee SD; Chang B; Jin DH; Jung SI; Park MY; Han Y; Yang Y; Il Kim K; Lim JS; Kang YS; Lee MS
    Free Radic Biol Med; 2012 Oct; 53(8):1607-15. PubMed ID: 22892142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytotoxicity of ascorbate, lipoic acid, and other antioxidants in hollow fibre in vitro tumours.
    Casciari JJ; Riordan NH; Schmidt TL; Meng XL; Jackson JA; Riordan HD
    Br J Cancer; 2001 Jun; 84(11):1544-50. PubMed ID: 11384106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitamin C: from popular food supplement to specific drug.
    Goldenberg H
    Forum Nutr; 2003; 56():42-5. PubMed ID: 15806791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New evidence for antioxidant properties of vitamin C.
    Vojdani A; Bazargan M; Vojdani E; Wright J
    Cancer Detect Prev; 2000; 24(6):508-23. PubMed ID: 11198264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of choline ascorbate on the blood levels of ascorbic acid in humans.
    Yillar DO; Akkan AG; Akcasu A; Ozüner Z
    Int J Clin Pharmacol Ther Toxicol; 1991 Jun; 29(6):228-30. PubMed ID: 1869344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.